3.87

1.78% -0.07

Qualigen Therapeutics Inc (QLGN)

Überblick Nachrichten Preisverlauf Financials Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

$3.94

Offen:

$3.97

24-Stunden-Volumen:

38,005

Relative Volume:

0.68

Marktkapitalisierung:

$2.86M

Einnahmen:

$4.79M

Nettoeinkommen (Verlust:

$-13.42M

KGV:

-1.4549

EPS:

-2.66

Netto-Cashflow:

$-10.30M

1W Leistung:

+7.80%

1M Leistung:

+17.63%

6M Leistung:

+7.50%

1J Leistung:

-74.07%

1-Tages-Spanne:

$3.75

$4.14

1-Wochen-Bereich:

$3.5227

$4.14

52-Wochen-Spanne:

$2.85

$29.43

Qualigen Therapeutics Inc Stock (QLGN) Company Profile

Firmenname

Qualigen Therapeutics Inc

Sektor

Healthcare (1170)

Branche

Biotechnology (671)

Telefon

(760) 918-9165

Adresse

2042 CORTE DEL NOGAL, CALIFORNIA

Mitarbeiter

Twitter

Nächster Verdiensttermin

2024-11-12

Neueste SEC-Einreichungen

QLGN's Discussions on Twitter

Vergleichen Sie QLGN mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
QLGN Qualigen Therapeutics Inc	3.87	2.64M	4.79M	-13.42M	-10.30M	-2.66
ONC Beigene Ltd Adr	228.38	25.07B	3.81B	-644.79M	-669.77M	-6.24
VRTX Vertex Pharmaceuticals Inc	438.65	109.14B	11.10B	-988.90M	-1.26B	-3.92
AKTX Akari Therapeutics Plc Adr	1.27	36.39M	0	0	0	0.00
REGN Regeneron Pharmaceuticals Inc	594.32	56.98B	14.09B	4.50B	2.96B	39.28
VRNA Verona Pharma Plc Adr	71.31	5.39B	0	-153.72M	-103.81M	-2.00

Qualigen Therapeutics Inc Aktie (QLGN) Neueste Nachrichten

May 01, 2025

Qualigen Therapeutics, Inc. Faces Nasdaq Delisting Due to Late Filing of 2024 Form 10-K - Nasdaq

May 01, 2025

Qualigen Therapeutics, Inc. Receives Notification of - GlobeNewswire

May 01, 2025

Qualigen Therapeutics, Inc. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Annual Report on Form 10-K - TradingView

May 01, 2025

Apr 10, 2025

QLGN stock touches 52-week low at $2.9 amid market challenges By Investing.com - Investing.com South Africa

Apr 10, 2025

QLGN stock touches 52-week low at $2.9 amid market challenges - Investing.com India

Apr 10, 2025

Apr 09, 2025

12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga

Apr 09, 2025

Apr 01, 2025

Qualigen Therapeutics Delays Yearly Financial Report - TipRanks

Apr 01, 2025

Qualigen seeks to enter the $10 Billion CABG market with non-binding MOU to acquire Marizyme - GlobeNewswire

Apr 01, 2025

Qualigen Therapeutics to acquire Marizyme in strategic move - Investing.com

Apr 01, 2025

Qualigen Therapeutics to acquire Marizyme in strategic move By Investing.com - Investing.com South Africa

Apr 01, 2025

Feb 16, 2025

Qualigen Therapeutics, Inc. (NASDAQ:QLGN) Short Interest Up 49.4% in January - Defense World

Feb 16, 2025

Jan 28, 2025

Qualigen to invest in NanoSynex, stock tumbles 21% - MSN

Jan 28, 2025

Qualigen Therapeutics Invests in NanoSynex’s Growth - TipRanks

Jan 28, 2025

Qualigen to participate in next funding round for NanoSynex - GlobeNewswire

Jan 28, 2025

This Breakthrough Could Cut Antibiotic Testing Time in HalfQualigen's Strategic Investment - StockTitan

Jan 28, 2025

Jan 17, 2025

Microbiomes Market to Grow by USD 1.13 Billion (2024-2028), Driven by Rising Disease Prevalence; AI Impact on Market TrendsTechnavio - The Malaysian Reserve

Jan 17, 2025

Jan 10, 2025

Qualigen Therapeutics (NASDAQ:QLGN) Stock Price Down 5.2% – Time to Sell? - Defense World

Jan 10, 2025

Qualigen Therapeutics (NASDAQ:QLGN) Shares Down 5.2% – Here’s Why - Defense World

Jan 10, 2025

Dec 19, 2024

Qualigen Therapeutics (NASDAQ:QLGN) Trading Down 7.8% – Time to Sell? - Defense World

Dec 19, 2024

Dec 10, 2024

SEC Form S-1 filed by Qualigen Therapeutics Inc. - Quantisnow

Dec 10, 2024

Dec 06, 2024

Qualigen Therapeutics regains compliance with Nasdaq's listing requirements - MSN

Dec 06, 2024

Dec 05, 2024

Qualigen Therapeutics regains Nasdaq compliance By Investing.com - Investing.com UK

Dec 05, 2024

Qualigen Therapeutics Announces Regained Compliance with - GlobeNewswire

Dec 05, 2024

Qualigen Therapeutics Announces Regained Compliance with Nasdaq's Minimum Bid Price Requirement and the Equity Requirement - Yahoo Finance

Dec 05, 2024

Nov 25, 2024

Univest Securities, LLC Announces Successful Closing of $5.1 Million Private Placement for Qualigen Therapeutics, Inc. (NASDAQ: QLGN) - The Manila Times

Nov 25, 2024

Univest Securities, LLC Announces Successful Closing of - GlobeNewswire

Nov 25, 2024

Nov 22, 2024

Qualigen Therapeutics, Inc. announced that it expects to receive $5.1 million in funding - Marketscreener.com

Nov 22, 2024

Nov 19, 2024

Qualigen Therapeutics secures $4.5 million in funding By Investing.com - Investing.com South Africa

Nov 19, 2024

Qualigen Therapeutics secures $4.5 million in funding - Investing.com India

Nov 19, 2024

Qualigen Therapeutics Announces $4.5 Million Private Placement of Convertible Preferred Shares - The Manila Times

Nov 19, 2024

Nov 18, 2024

Qualigen Therapeutics (NASDAQ:QLGN) versus Ionis Pharmaceuticals (NASDAQ:IONS) Head-To-Head Review - Defense World

Nov 18, 2024

Nov 15, 2024